Access to weight-loss drugs is improving
According to the Phase 3 trial involving around 2,500 patients, people taking the highest dose of Retatrutide lost an average of 28.3 per cent of their body weight, approximately 70 pounds, over 80 weeks
reports of priapism, renal infarction, eruptive nevi, and melanoma in situ
Tesamorelin (Injection) Tesamorelin is commonly used in metabolism and body composition protocols for its potential role in supporting visceral fat reduction (deep abdominal fat around organs) and improving metabolic markers for certain individuals
FAQs The core advantages are that it brightens the skin, fades pigmentation, enhances a glow, and prevents destruction by free radicals
2025;17(7):e89020